Abstract
Oral squamous cell carcinoma (OSCC) of the tongue is the most common type of oral cavity cancer, and tumor depth of invasion (DOI) is an important prognostic factor. In this study, we investigated the accuracy of intraoral ultrasound and magnetic resonance imaging (MRI) for assessing DOI in patients with OSCC. Histopathological measurement of DOI was used as a reference standard. We conducted a prospective study including patients planned for surgical treatment of OSCC in the tongue. The DOI was measured in an outpatient setting by intraoral ultrasound and MRI, and was compared to the histopathological DOI measurements. Bland–Altman analysis compared the mean difference and 95% limits of agreement (LOA) for ultrasound and MRI, and the Wilcoxon signed-rank test was used to test for significance. The correlation was evaluated using Pearson’s correlation coefficient. We included 30 patients: 26 with T1 or T2 tumors, and 4 with T3 tumors. The mean difference from histopathology DOI was significantly lower for ultrasound compared to MRI (0.95 mm [95% LOA −4.15 mm to 6.06 mm] vs. 1.90 mm [95% LOA −9.02 mm and 12.81 mm], p = 0.023). Ultrasound also led to significantly more correct T-stage classifications in 86.7% (26) of patients compared to 56.7% (17) for MRI, p = 0.015. The Pearson correlation between MRI and histopathology was 0.57 (p < 0.001) and the correlation between ultrasound and histopathology was 0.86 (p < 0.001). This prospective study found that intraoral ultrasound is more accurate than MRI in assessing DOI and for the T-staging of oral tongue cancers. Clinical practice and guidelines should implement intraoral ultrasound accordingly.
Keywords: oral cancer; tongue cancer; staging; depth of invasion; intraoral ultrasound; MRI; pathology
Keywords: oral cancer; tongue cancer; staging; depth of invasion; intraoral ultrasound; MRI; pathology
Originalsprog | Engelsk |
---|---|
Artikelnummer | 637 |
Tidsskrift | Cancers |
Vol/bind | 16 |
Udgave nummer | 3 |
Antal sider | 11 |
ISSN | 2072-6694 |
DOI | |
Status | Udgivet - 2024 |
Bibliografisk note
Funding Information:This research work was supported by the Novo Nordisk Foundation [grant number NNF21SA0069151]. Role of the Funding Source: the Novo Nordisk Foundation has supported Tobias Todsen and his group in cancer-related ultrasound research.
Publisher Copyright:
© 2024 by the authors.